HIF1A |
dendritic cells |
LPS, 0 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0259.1
...
|
HIF1A |
dendritic cells |
LPS, 120 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0259.1
...
|
HIF1A |
dendritic cells |
LPS, 30 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0259.1
...
|
HIF1A |
dendritic cells |
LPS, 60 min |
Permissive
|
Mus musculus |
GSE36099
...
|
MA0259.1
...
|
HIF1A |
U2OS (osteosarcoma) |
peak DMOG |
Permissive
|
Homo sapiens |
GSE85096
...
|
MA0259.1
...
|
HIF1A |
U2OS (osteosarcoma) |
trough DMOG |
Permissive
|
Homo sapiens |
GSE85096
...
|
MA0259.1
...
|
HIF1A |
U2OS (osteosarcoma) |
peak DMSO |
Permissive
|
Homo sapiens |
GSE85096
...
|
MA0259.1
...
|
HIF1A |
U2OS (osteosarcoma) |
through DMSO |
Permissive
|
Homo sapiens |
GSE85096
...
|
MA0259.1
...
|
HIF1A |
Th17-cells |
48h |
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0259.1
...
|
HIF1A |
Th17-cells |
48h |
Permissive
Robust
|
Mus musculus |
GSE40918
...
|
MA0259.1
...
|
HIF1A |
HKC8 (kidney proximal tubule cell line) |
Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HKC8 (kidney proximal tubule cell line) |
Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours, HIF2a knockout |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
RCC4 (kidney cancer cell line) |
Treatment: degree of hypoxia - normoxia |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
RCC4 (kidney cancer cell line) |
Treatment: degree of hypoxia - normoxia |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HepG2 (hepatoblastoma) |
Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HepG2 (hepatoblastoma) |
Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HKC8 (kidney proximal tubule cell line) |
Treatment: degree of hypoxia 0.5%, duration of hypoxia 6 hours |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HKC8 (kidney proximal tubule cell line) |
Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours |
Permissive
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HKC8 (kidney proximal tubule cell line) |
Treatment: degree of hypoxia 0.5%, duration of hypoxia 48 hours |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HKC8 (kidney proximal tubule cell line) |
Treatment: degree of hypoxia 3.0%, duration of hypoxia 6 hours |
Permissive
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HKC8 (kidney proximal tubule cell line) |
Treatment: degree of hypoxia 0.5%, duration of hypoxia 16 hours |
Permissive
Robust
|
Homo sapiens |
GSE120885
...
|
MA0259.1
...
|
HIF1A |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Passage: 4-6 |
Permissive
|
Homo sapiens |
GSE89836
...
|
MA0259.1
...
|
HIF1A |
frontal cortex |
Genotype: wildtype Treament: no |
Permissive
|
Mus musculus |
GSE106220
...
|
MA0259.1
...
|
HIF1A |
frontal cortex |
Genotype: wildtype Treament: environmental stress |
Permissive
|
Mus musculus |
GSE106220
...
|
MA0259.1
...
|
HIF1A |
PC3(bone mets prostate adenocarcinoma) |
Treatment: siCtrl; |
Permissive
Robust
|
Homo sapiens |
GSE106305
...
|
MA0259.1
...
|
HIF1A |
PC3(bone mets prostate adenocarcinoma) |
Treatment: siOC2; Genotype: OC2 knockout ; |
Permissive
|
Homo sapiens |
GSE106305
...
|
MA0259.1
...
|
HIF1A |
PC3(bone mets prostate adenocarcinoma) |
Treatment: hypoxia(0.2% O2), siCtrl; |
Permissive
Robust
|
Homo sapiens |
GSE106305
...
|
MA0259.1
...
|
HIF1A |
PC3(bone mets prostate adenocarcinoma) |
Treatment: hypoxia(0.2% O2), siSMAD3; Genotype: SMAD3 knockout; |
Permissive
Robust
|
Homo sapiens |
GSE106305
...
|
MA0259.1
...
|
HIF1A |
T47D (invasive ductal carcinoma) |
HAEGIN2 |
Permissive
|
Homo sapiens |
GSE59935
|
MA1106.1
|
HIF1A |
E12.5 embryonic heart |
|
Permissive
Robust
|
Mus musculus |
GSE61247
...
|
MA0259.1
...
|
HIF1A |
U2OS (osteosarcoma) |
|
Permissive
|
Homo sapiens |
GSE69100
...
|
MA0259.1
...
|
HIF1A |
melan-Ink4a-Arf-null melanocytes |
|
Permissive
Robust
|
Mus musculus |
GSE86554
...
|
MA0259.1
...
|
HIF1A |
RCC 7860 (Renal cell carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE34871
|
MA1106.1
|
HIF1A |
|
|
Permissive
|
Homo sapiens |
GSE67237
|
MA1106.1
|
HIF1A |
|
|
Permissive
|
Homo sapiens |
GSE67237
|
MA1106.1
|
HIF1A |
NCI-H1299 (large cell lung carcinoma) |
|
Permissive
|
Homo sapiens |
GSE76770
|
MA1106.1
|
HIF1A |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
HYPOX |
Permissive
Robust
|
Homo sapiens |
GSE39089
|
MA1106.1
|
HIF1A |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
NOMO |
Permissive
|
Homo sapiens |
GSE39089
|
MA1106.1
|
HIF1A |
macrophages |
HYPO_IL |
Permissive
Robust
|
Homo sapiens |
GSE43109
|
MA1106.1
|
HIF1A |
macrophages |
NORMO_IL |
Permissive
|
Homo sapiens |
GSE43109
|
MA1106.1
|